A detailed history of Wedmont Private Capital transactions in Amgen Inc stock. As of the latest transaction made, Wedmont Private Capital holds 5,419 shares of AMGN stock, worth $1.56 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,419
Previous 5,164 4.94%
Holding current value
$1.56 Million
Previous $1.61 Million 8.25%
% of portfolio
0.1%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$309.38 - $337.38 $78,891 - $86,031
255 Added 4.94%
5,419 $1.75 Million
Q2 2024

Jul 15, 2024

BUY
$262.75 - $319.31 $166,058 - $201,803
632 Added 13.95%
5,164 $1.61 Million
Q1 2024

Apr 10, 2024

BUY
$268.87 - $324.56 $7,797 - $9,412
29 Added 0.64%
4,532 $1.29 Million
Q4 2023

Jan 09, 2024

BUY
$255.7 - $288.46 $219,646 - $247,787
859 Added 23.57%
4,503 $1.3 Million
Q3 2023

Oct 10, 2023

BUY
$218.65 - $271.46 $172,296 - $213,910
788 Added 27.59%
3,644 $979,000
Q2 2023

Jul 17, 2023

SELL
$214.27 - $253.37 $97,921 - $115,790
-457 Reduced 13.79%
2,856 $634,000
Q1 2023

Apr 11, 2023

SELL
$225.79 - $275.2 $87,832 - $107,052
-389 Reduced 10.51%
3,313 $800,000
Q4 2022

Jan 09, 2023

BUY
$229.03 - $291.01 $138,563 - $176,061
605 Added 19.54%
3,702 $0
Q3 2022

Oct 03, 2022

SELL
$224.46 - $253.15 $11,447 - $12,910
-51 Reduced 1.62%
3,097 $698,000
Q2 2022

Jul 11, 2022

BUY
$230.71 - $256.74 $91,130 - $101,412
395 Added 14.35%
3,148 $766,000
Q1 2022

Apr 05, 2022

BUY
$219.27 - $242.57 $157,216 - $173,922
717 Added 35.22%
2,753 $674,000
Q4 2021

Jan 14, 2022

BUY
$198.88 - $227.6 $404,919 - $463,393
2,036 New
2,036 $470,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wedmont Private Capital Portfolio

Follow Wedmont Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedmont Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Wedmont Private Capital with notifications on news.